These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3941004)

  • 1. Synthetic Salmonella-type lipid A antigen with high serological specificity.
    Kasai N; Arata S; Mashimo J; Okuda K; Aihara Y; Kotani S; Takada H; Shiba T; Kusumoto S; Imoto M
    Infect Immun; 1986 Jan; 51(1):43-8. PubMed ID: 3941004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low endotoxic activities of synthetic Salmonella-type lipid A with an additional acyloxyacyl group on the 2-amino group of beta (1-6) glucosamine disaccharide 1,4'-bisphosphate.
    Kotani S; Takada H; Takahashi I; Tsujimoto M; Ogawa T; Ikeda T; Harada K; Okamura H; Tamura T; Tanaka S
    Infect Immun; 1986 Jun; 52(3):872-84. PubMed ID: 3011676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro antigenic reactivity of synthetic lipid A analogues as determined by monoclonal and conventional antibodies.
    Kasai N; Arata S; Mashimo J; Okuda K; Aihara Y; Kotani S; Takada H; Shiba T; Kusumoto S
    Biochem Biophys Res Commun; 1985 Apr; 128(2):607-12. PubMed ID: 2581565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic lipid A with endotoxic and related biological activities comparable to those of a natural lipid A from an Escherichia coli re-mutant.
    Kotani S; Takada H; Tsujimoto M; Ogawa T; Takahashi I; Ikeda T; Otsuka K; Shimauchi H; Kasai N; Mashimo J
    Infect Immun; 1985 Jul; 49(1):225-37. PubMed ID: 3891627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural heterogeneity regarding local Shwartzman activity of lipid A.
    Mashimo J; Tanaka C; Arata S; Akiyama Y; Hata S; Hirayama T; Egawa K; Kasai N
    Microbiol Immunol; 1988; 32(7):653-66. PubMed ID: 3057331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunobiological properties of chemically defined lipid A from lipopolysaccharide of Porphyromonas (Bacteroides) gingivalis.
    Ogawa T
    Eur J Biochem; 1994 Feb; 219(3):737-42. PubMed ID: 8112323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immunogenicity and antigenicity of lipid A are influenced by its physicochemical state and environment.
    Brade L; Brandenburg K; Kuhn HM; Kusumoto S; Macher I; Rietschel ET; Brade H
    Infect Immun; 1987 Nov; 55(11):2636-44. PubMed ID: 3666956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunobiological activities of synthetic lipid A analogs and related compounds as compared with those of bacterial lipopolysaccharide, re-glycolipid, lipid A, and muramyl dipeptide.
    Kotani S; Takada H; Tsujimoto M; Ogawa T; Mori Y; Sakuta M; Kawasaki A; Inage M; Kusumoto S; Shiba T; Kasai N
    Infect Immun; 1983 Aug; 41(2):758-73. PubMed ID: 6409812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutralization of Shwartzman-inducing activity by antibodies recognizing the Re core or lipid A structures of lipopolysaccharide from Salmonella minnesota R595 and Pseudomonas vesicularis JCM1477.
    Mashimo J; Mizutani T; Mita A; Kasai N
    Microbiol Immunol; 1991; 35(6):423-34. PubMed ID: 1921759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epitope specificities of murine monoclonal and rabbit polyclonal antibodies against enterobacterial lipopolysaccharides of the Re chemotype.
    Rozalski A; Brade L; Kosma P; Appelmelk BJ; Krogmann C; Brade H
    Infect Immun; 1989 Sep; 57(9):2645-52. PubMed ID: 2474499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Requirement of a properly acylated beta(1-6)-D-glucosamine disaccharide bisphosphate structure for efficient manifestation of full endotoxic and associated bioactivities of lipid A.
    Takahashi I; Kotani S; Takada H; Tsujimoto M; Ogawa T; Shiba T; Kusumoto S; Yamamoto M; Hasegawa A; Kiso M
    Infect Immun; 1987 Jan; 55(1):57-68. PubMed ID: 3539807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical structure and biologic activity of bacterial and synthetic lipid A.
    Rietschel ET; Brade L; Brandenburg K; Flad HD; de Jong-Leuveninck J; Kawahara K; Lindner B; Loppnow H; Lüderitz T; Schade U
    Rev Infect Dis; 1987; 9 Suppl 5():S527-36. PubMed ID: 3317748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of fatty acid substituents of chemically synthesized lipid A-subunit analogs in the expression of immunopharmacological activity.
    Kumazawa Y; Nakatsuka M; Takimoto H; Furuya T; Nagumo T; Yamamoto A; Homma Y; Inada K; Yoshida M; Kiso M
    Infect Immun; 1988 Jan; 56(1):149-55. PubMed ID: 3257202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunopharmacological activities of a synthetic counterpart of a biosynthetic lipid A precursor molecule and of its analogs.
    Takada H; Kotani S; Tsujimoto M; Ogawa T; Takahashi I; Harada K; Katsukawa C; Tanaka S; Shiba T; Kusumoto S
    Infect Immun; 1985 Apr; 48(1):219-27. PubMed ID: 3980084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The chemical structure of lipid A. Demonstration of amide-linked 3-acyloxyacyl residues in Salmonella minnesota Re lipopolysaccharide.
    Wollenweber HW; Broady KW; Lüderitz O; Rietschel ET
    Eur J Biochem; 1982 May; 124(1):191-8. PubMed ID: 7084225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural requirements for inducing in vitro B lymphocyte activation by chemically synthesized derivatives related to the nonreducing D-glucosamine subunit of lipid A.
    Kumazawa Y; Matsuura M; Maruyama T; Homma JY; Kiso M; Hasegawa A
    Eur J Immunol; 1986 Sep; 16(9):1099-103. PubMed ID: 3489621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-reactivity of monoclonal antibodies and sera directed against lipid A and lipopolysaccharides.
    Kuhn HM
    Infection; 1993; 21(3):179-86. PubMed ID: 8365817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunobiological activities of chemically defined lipid A from Helicobacter pylori LPS in comparison with Porphyromonas gingivalis lipid A and Escherichia coli-type synthetic lipid A (compound 506).
    Ogawa T; Suda Y; Kashihara W; Hayashi T; Shimoyama T; Kusumoto S; Tamura T
    Vaccine; 1997 Oct; 15(15):1598-605. PubMed ID: 9364689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Newer aspects of the chemical structure and biological activity of bacterial endotoxins.
    Rietschel ET; Brade H; Brade L; Kaca W; Kawahara K; Lindner B; Lüderitz T; Tomita T; Schade U; Seydel U
    Prog Clin Biol Res; 1985; 189():31-51. PubMed ID: 2413465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural features that influence the ability of lipid A and its analogs to abolish expression of suppressor T cell activity.
    Baker PJ; Hraba T; Taylor CE; Myers KR; Takayama K; Qureshi N; Stuetz P; Kusumoto S; Hasegawa A
    Infect Immun; 1992 Jul; 60(7):2694-701. PubMed ID: 1535339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.